Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2001

View Archived Issues

GT-160-246 as a promising approach to C. difficile colitis

Phase IIb clinical trial of ATL-1251 to begin in U.K. in IBS patients

Proof of principle demonstrated in phase II studies for novel cardiology candidate therapeutic

Bayer and GeneData extend successful genomics-based antibiotic discovery collaboration

Muscarinic M3 antagonist YM-905 studied in experimental models of IBS symptoms

Castor oil component demonstrates both pro- and antiinflammatory properties

AnorMED makes significant strides in development programs

AJ-2615, a dual calcium antagonist and alpha1-adrenoceptor blocker: implications for CABG patients

Solvay identifies new atypical antipsychotic candidate

Long-term AICAR has beneficial metabolic and cardiovascular effects in rat IRS model

Methods and compositions for inflammatory diseases disclosed by GSK

Synthesis and use of new macrolides described by Pfizer

Anti-TNF agents in development at Sanofi-Synthelabo

Inhibitors of cysteine proteases of the ICE/ced-3 family identified by Idun

Shionogi patents potent new antitumor agents useful against solid tumors

New ADIR compounds useful for improving endothelial dysfunction

Oxazolidinone antibacterial agents discovered by Abbott

Clinical development update presented by Novuspharma for second quarter

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...